137 related articles for article (PubMed ID: 9932156)
1. PSA screening--current controversy.
Svetec D; Thompson IM
Ann Oncol; 1998 Dec; 9(12):1283-8. PubMed ID: 9932156
[TBL] [Abstract][Full Text] [Related]
2. PSA screening for prostate cancer: the current controversy.
de Koning HJ; Schröder FH
Ann Oncol; 1998 Dec; 9(12):1293-6. PubMed ID: 9932158
[No Abstract] [Full Text] [Related]
3. Screening for prostate cancer.
Neal DE; Donovan JL
Ann Oncol; 1998 Dec; 9(12):1289-92. PubMed ID: 9932157
[No Abstract] [Full Text] [Related]
4. PSA screening for prostate cancer: the current controversy--a viewpoint. Patient Outcomes Research Team for Prostatic Diseases.
Barry MJ
Ann Oncol; 1998 Dec; 9(12):1279-82. PubMed ID: 9932155
[TBL] [Abstract][Full Text] [Related]
5. Prostate specific antigen (PSA) testing as screening for prostate cancer: the current controversy.
Boyle P
Ann Oncol; 1998 Dec; 9(12):1263-4. PubMed ID: 9932152
[No Abstract] [Full Text] [Related]
6. Overdiagnosis of prostate carcinoma by screening: an estimate based on the results of the Florence Screening Pilot Study.
Zappa M; Ciatto S; Bonardi R; Mazzotta A
Ann Oncol; 1998 Dec; 9(12):1297-300. PubMed ID: 9932159
[TBL] [Abstract][Full Text] [Related]
7. The prostate cancer pseudo-epidemic.
Adami HO
Acta Oncol; 2010 Apr; 49(3):298-304. PubMed ID: 20397765
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis of cancer of the prostate (I): Advancements in knowledge and practice since the consensus conference of 1989. The "Cancer of the Prostate" subcommittee of the Committee of Oncology of the French Association of Urology].
Villers A; Grosclaude P; Haillot O; Abbou CC; Richard F; Boccon-Gibod L
Prog Urol; 1997 Jun; 7(3):508-15. PubMed ID: 9273082
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic drift in the reporting of cancer incidence.
Bailar JC
J Natl Cancer Inst; 1998 Jun; 90(11):863-4. PubMed ID: 9625178
[No Abstract] [Full Text] [Related]
10. Early-stage prostate cancer, PSA screening rates decline.
Printz C
Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
[No Abstract] [Full Text] [Related]
11. [Prostate Specific Antigen (PSA), yet how much damage?].
Braillon A; Hill C; Dubois G
Presse Med; 2012 May; 41(5):482-5. PubMed ID: 22336482
[TBL] [Abstract][Full Text] [Related]
12. American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.
Carter HB
BJU Int; 2013 Sep; 112(5):543-7. PubMed ID: 23924423
[TBL] [Abstract][Full Text] [Related]
13. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
Lynch MJ
J Urol; 2005 Sep; 174(3):1155; author reply 1155-6. PubMed ID: 16094096
[No Abstract] [Full Text] [Related]
14. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis.
Tawfik A
Ont Health Technol Assess Ser; 2015; 15(11):1-37. PubMed ID: 26366237
[TBL] [Abstract][Full Text] [Related]
15. [Screening for the early diagnosis of prostatic carcinoma in Ossola: results after 1 year of effort].
Pagani G; Iannicelli P; Rosa A; Aimè G; Ceratti G; Cobianchi PG
Arch Ital Urol Androl; 1994 Feb; 66(1):47-50. PubMed ID: 7516781
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen screening: pro.
Loeb S; Catalona WJ
Curr Opin Urol; 2010 May; 20(3):185-8. PubMed ID: 20224413
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer screening.
Roetzheim RG; Herold AH
Prim Care; 1992 Sep; 19(3):637-49. PubMed ID: 1384077
[TBL] [Abstract][Full Text] [Related]
18. [Advantages and risks of the use of prostate-specific antigen (PSA) in the health-care area No. 4 of Gijon (Asturias)].
Cepeda Piorno J; Rivas del Fresno M; Fuente Martín E; González García E; Muruamendiaraz Fernández V; Fernández Rodríguez E
Arch Esp Urol; 2005 Jun; 58(5):403-11. PubMed ID: 16078781
[TBL] [Abstract][Full Text] [Related]
19. A literature review of cost-effectiveness analyses of prostate-specific antigen test in prostate cancer screening.
Garg V; Gu NY; Borrego ME; Raisch DW
Expert Rev Pharmacoecon Outcomes Res; 2013 Jun; 13(3):327-42. PubMed ID: 23763530
[TBL] [Abstract][Full Text] [Related]
20. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
Hoeltl W; Müller MM; Lunglmayr G
J Urol; 2005 Jun; 173(6):2205; author reply 2205-6. PubMed ID: 15879895
[No Abstract] [Full Text] [Related]
[Next] [New Search]
